Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.34
-0.1100-2.02%
Volume:891.38K
Turnover:4.71M
Market Cap:290.16M
PE:-1.48
High:5.44
Open:5.24
Low:5.12
Close:5.45
Loading ...

Ethiopian police raids private news outlet over alleged violence-inciting documentary

CoinMarketCap
·
23 Apr

Institutional investors in Emergent BioSolutions Inc. (NYSE:EBS) see US$31m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.
·
11 Apr

Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?

Zacks
·
10 Apr

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple

Reuters
·
01 Apr

BUZZ-Emergent BioSolutions up after authorizing $50 million stock repurchase plan

Reuters
·
31 Mar

Emergent BioSolutions Shares Rise 13% After Co Authorizes $50 Mln Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Authorizes $50 Million Stock Buyback Program

MT Newswires Live
·
31 Mar

Emergent BioSolutions Shares Rise 3.2% Premarket After Co Authorizes $50 Mln Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Inc - Authorizes $50 Million Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Announces Stock Repurchase Program

THOMSON REUTERS
·
31 Mar

Emergent BioSolutions Announces Stock Repurchase Program

GlobeNewswire
·
31 Mar

DEXIS to Showcase Cutting-Edge Innovations at IDS 2025

ACCESS Newswire
·
24 Mar

Emergent Biosolutions Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Mar

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

GlobeNewswire
·
21 Mar

Hikma: Aims to Make Kloxxado Available via Prescription as Early as 2026

THOMSON REUTERS
·
20 Mar

Hikma Announces Health Canada Approval of Kloxxado® (Naloxone Hcl) Nasal Spray 8 Mg

THOMSON REUTERS
·
20 Mar

Emergent BioSolutions Completes Sale of Baltimore-Bayview Facility to Syngene International

MT Newswires Live
·
20 Mar

BRIEF-Emergent Biosolutions finalizes sale of Baltimore-Bayview manufacturing site to Syngene International

Reuters
·
20 Mar

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

THOMSON REUTERS
·
20 Mar